MyAverix Finance
SHE · Healthcare
Betta Pharmaceuticals Co Ltd (300558)
Drug Manufacturers - Specialty & Generic
Betta Pharmaceuticals Co Ltd (300558) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $18.21B, P/E ratio is 60.11, net margin is 9.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300558
Betta Pharmaceuticals Co Ltd (300558) — FAQ
What is Betta Pharmaceuticals Co Ltd's market cap?
Betta Pharmaceuticals Co Ltd (300558) has a reported market cap of $18.21B (data as of 2026-03-28).
What is 300558's P/E ratio?
The price-to-earnings (P/E) ratio for Betta Pharmaceuticals Co Ltd (300558) is 60.11 (data as of 2026-03-28).
Does Betta Pharmaceuticals Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Betta Pharmaceuticals Co Ltd (300558). Check the MyAverix Finance app for the latest dividend data.
What sector is Betta Pharmaceuticals Co Ltd in?
Betta Pharmaceuticals Co Ltd (300558) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300558 listed on?
300558 is listed on SHE.
What is Betta Pharmaceuticals Co Ltd's net margin?
Betta Pharmaceuticals Co Ltd (300558) reports a net margin of 9.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.